LIVMARLI Peers are patients and caregivers who share their experiences of living with or caring for someone living with cholestatic pruritus (itch) in Alagille syndrome (ALGS) and treatment with LIVMARLI.

Register today by calling 1-855-370-1371 or sign up below.

^*Required

First Name^*

Last Name^*

Email^*

Phone Number^*

State^*

Are you...:^*

Someone who is diagnosed with Alagille syndrome? A direct caregiver for someone diagnosed with Alagille syndrome?

How did you hear about this program?

Other

Are you or a loved one currently taking LIVMARLI?

Yes No

What time zone are you located in?^*

By checking this box, I agree to receive information from Mirum Pharmaceuticals about its products and services. I understand that my information may be used by Mirum Pharmaceuticals and companies working with Mirum for marketing purposes; to conduct market research; and to develop future products, services, and programs. The information I’ve provided will be used in accordance with the Mirum Pharmaceuticals Privacy Policy. I certify that I am 18 years of age or older.^*

I agree to receive text messages at the phone number provided. Data rates may apply.

If you later wish to opt out of receiving information, please call 1-855-370-1371.

SUBMIT

Thank you for submitting the form.

Our Team will follow up within two business days.

There was a problem

Please check your information and try again

Return to form

IMPORTANT SAFETY INFORMATION

INDICATION

LIVMARLI is a prescription medicine used to treat cholestatic pruritus (itch) in patients with Alagille syndrome 3 months of age and older. It is not known if LIVMARLI is safe and effective in children under 3 months of age or in adults 65 years and older.

IMPORTANT SAFETY INFORMATION

What are the possible side effects of LIVMARLI?

LIVMARLI can cause serious side effects, including:

Changes in liver tests. Changes in certain liver tests are common in patients with Alagille syndrome but may worsen during treatment with LIVMARLI. These changes may be a sign of liver injury and can be serious. Your health care provider should do blood tests before starting and during treatment to check your liver function. Tell your health care provider right away if you get any signs or symptoms of liver problems, including:

nausea or vomiting
skin or the white part of the eye turns yellow
dark or brown urine
pain on the right side of the stomach (abdomen)
loss of appetite

Stomach and intestinal (gastrointestinal) problems. LIVMARLI can cause stomach and intestinal problems, including diarrhea, stomach pain, and vomiting during treatment. Tell your health care provider right away if you have any of these symptoms more often or more severely than normal for you.

A condition called Fat-Soluble Vitamin (FSV) Deficiency caused by low levels of certain vitamins (vitamins A, D, E, and K) stored in body fat. FSV deficiency is common in patients with Alagille syndrome but may worsen during treatment. Your health care provider should do blood tests before starting and during treatment.

Other common side effects reported during treatment were gastrointestinal bleeding and bone fractures.

Tell your health care provider about all medicines that you take. LIVMARLI may affect the way some other medicines work, and some other medicines may affect the way LIVMARLI works. If you take a medicine that lowers cholesterol by binding bile acids, such as cholestyramine, colesevelam, or colestipol, take it at least 4 hours before or 4 hours after you take LIVMARLI.

LIVMARLI is taken by mouth, 1 time each day, 30 minutes before a meal in the morning. Be sure to use the provided oral dosing dispenser to accurately measure the dose of medicine.

These are not all of the possible side effects of LIVMARLI. Call your health care provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.